Benzinga·2025-11-04 14:00Core Insights - U.S. stock futures are down, with Dow futures dropping over 300 points [1] - Insperity Inc reported disappointing third-quarter results, leading to a significant drop in its stock price [1][2] Company Performance - Insperity reported a quarterly loss of $0.20 per share, missing the analyst consensus estimate of $0.22 per share [2] - Quarterly sales for Insperity were $1.623 billion, falling short of the analyst consensus estimate of $1.632 billion [2] - Insperity's shares fell 31.3% to $31.00 in pre-market trading following the earnings report [2] Other Companies Impacted - Sarepta Therapeutics Inc saw a decline of 38.7% to $14.98 after reporting third-quarter results and failing to achieve statistical significance in its ESSENCE study [4] - Jeld-Wen Holding Inc's shares dropped 28.1% to $3.02 after reporting worse-than-expected third-quarter results and cutting FY25 guidance [4] - Ichor Holdings Ltd experienced a 26.2% decline to $16.77 after mixed third-quarter results and below-estimate fourth-quarter guidance [4] - Atlas Energy Solutions Inc's shares dipped 17.8% to $10.40 after reporting disappointing third-quarter results [4] - Navitas Semiconductor Corp fell 15.7% to $10.32 following its third-quarter results [4] - Uniqure NV's shares decreased 11.6% to $30.30 after a significant drop of 49% on Monday due to FDA concerns regarding its AMT-130 data [4] - Other companies like Ardelyx Inc, Genius Sports Limited, IAC Inc, and Archer-Daniels-Midland Company also reported declines in pre-market trading due to worse-than-expected financial results or lowered guidance [4]